Work

Deregulation of innate immune and inflammatory signaling in myelodysplastic syndromes

Year: 2015

Type: review

Source: Leukemia

DOI: 10.1038/leu.2015.69

Authors: I Gañán-Gómez, Y Wei, D T Starczynowski, S Colla, H Yang, M Cabrero-Calvo, Z S Bohannan, A Verma, U Steidl, G Garcia-Manero

Institutions: The University of Texas MD Anderson Cancer Center, Cincinnati Children's Hospital Medical Center, University of Cincinnati, Albert Einstein College of Medicine, Montefiore Medical Center

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: U.S. Department of Defense, Cancer Prevention and Research Institute of Texas, Edward P. Evans Foundation, National Institutes of Health, University of Texas MD Anderson Cancer Center, National Heart, Lung, and Blood Institute, National Cancer Institute, National Institute of Diabetes and Digestive and Kidney Diseases

Awards: G1468253849, Molecular Pathogenesis of MDS, Role of a Novel Homeobox Transcription Factor (HLX) in Acute Myeloid Leukemia, G293715275, Communication Between Patients and their Providers, G4276892241, G4550465470, Role of TRAF6 in Myelodysplastic Syndromes, Identification and characterization of genes in del(5q) myelodysplastic syndrome, G6736661663, Analysis of histone code alterations and the role of histone demethylase JMJD3 using CHIP-seq in myelodysplastic syndrome, G7761418987, G788993117, G9000114284, G9000248060, Cancer Center Support Grant

OpenAlex ID: W2020719716

FWCI: 3.39

Cites: 120

Cited by: 236

Related to: 10